高危神经母细胞瘤：我们何去何从？ - Suppr

Suppr

超能文献

High-risk neuroblastoma: where do we go?

作者信息

Cañete A

机构信息

Department of Paediatric Oncology, Hospital Universitari and Politecnic La Fe, Universitat de Valencia, Spain.

出版信息

Ann Oncol. 2020 Mar;31(3):326-327. doi: 10.1016/j.annonc.2019.12.003. Epub 2020 Jan 25.

DOI:10.1016/j.annonc.2019.12.003

PMID:32067674

Abstract

摘要

相似文献

High-risk neuroblastoma: where do we go?高危神经母细胞瘤：我们何去何从？

Ann Oncol. 2020 Mar;31(3):326-327. doi: 10.1016/j.annonc.2019.12.003. Epub 2020 Jan 25.

Incidence and risk factors of bacterial and fungal infection during induction chemotherapy for high-risk neuroblastoma.高危神经母细胞瘤诱导化疗期间细菌和真菌感染的发生率及危险因素

Pediatr Hematol Oncol. 2017 Aug;34(5):331-342. doi: 10.1080/08880018.2017.1396386. Epub 2017 Dec 4.

The degree of tumor volume reduction during the early phase of induction chemotherapy is an independent prognostic factor in patients with high-risk neuroblastoma.诱导化疗早期肿瘤体积减少的程度是高危神经母细胞瘤患者的独立预后因素。

Cancer. 2013 Feb 1;119(3):656-64. doi: 10.1002/cncr.27775. Epub 2012 Sep 5.

A systematic review of re-induction chemotherapy for children with relapsed high-risk neuroblastoma.复发高危神经母细胞瘤患儿再诱导化疗的系统评价

Eur J Cancer. 2019 Apr;111:50-58. doi: 10.1016/j.ejca.2018.12.032. Epub 2019 Feb 26.

Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.手术在诱导化疗反应不佳的高危神经母细胞瘤患者治疗中的作用。

J Pediatr Surg. 2014 Apr;49(4):528-33. doi: 10.1016/j.jpedsurg.2013.11.061. Epub 2013 Dec 1.

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.高危神经母细胞瘤患者接受拓扑替康和环磷酰胺联合诱导治疗的临床结局和预测治疗反应的预后因素：一项前瞻性多中心研究。

BMC Cancer. 2019 Oct 16;19(1):961. doi: 10.1186/s12885-019-6186-z.

Tumor histology during induction therapy in patients with high-risk neuroblastoma.高危神经母细胞瘤患者诱导治疗期间的肿瘤组织学。

Pediatr Blood Cancer. 2012 Sep;59(3):506-10. doi: 10.1002/pbc.24013. Epub 2011 Dec 11.

Clinical Significance of Persistent Tumor in Bone Marrow during Treatment of High-risk Neuroblastoma.高危神经母细胞瘤治疗期间骨髓中持续存在肿瘤的临床意义

J Korean Med Sci. 2015 Aug;30(8):1062-7. doi: 10.3346/jkms.2015.30.8.1062. Epub 2015 Jul 15.

Revised antiemetics guidelines and the impact on nutritional status during induction chemotherapy in children with high-risk neuroblastoma.高危神经母细胞瘤患儿诱导化疗期间修订止吐指南与营养状况的影响。

Pediatr Blood Cancer. 2018 Dec;65(12):e27386. doi: 10.1002/pbc.27386. Epub 2018 Sep 19.

Additional Therapies to Improve Metastatic Response to Induction Therapy in Children With High-risk Neuroblastoma.改善高危神经母细胞瘤患儿诱导治疗转移反应的额外疗法。

J Pediatr Hematol Oncol. 2015 Apr;37(3):e150-3. doi: 10.1097/MPH.0000000000000308.

引用本文的文献

Suppression of endoplasmic reticulum stress-dependent autophagy enhances cynaropicrin-induced apoptosis via attenuation of the P62/Keap1/Nrf2 pathways in neuroblastoma.内质网应激依赖性自噬的抑制通过减弱神经母细胞瘤中P62/Keap1/Nrf2信号通路增强了菜蓟苦素诱导的细胞凋亡。

Front Pharmacol. 2022 Sep 16;13:977622. doi: 10.3389/fphar.2022.977622. eCollection 2022.

Anti-tumor effect of Huaier extract against neuroblastoma cells .槐耳提取物对神经母细胞瘤细胞的抗肿瘤作用。

Int J Med Sci. 2021 Jan 1;18(4):1015-1023. doi: 10.7150/ijms.48219. eCollection 2021.

Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma.化疗后样本中磷酸化-ERK 的免疫组化染色是神经母细胞瘤预后的潜在预测指标。

Pediatr Surg Int. 2021 Feb;37(2):287-291. doi: 10.1007/s00383-020-04806-w. Epub 2021 Jan 4.

Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.基于生物信息学分析的 miRNA 芯片鉴定神经母细胞瘤中枢纽 miRNA 并构建 miRNA-mRNA 网络

Neurochem Res. 2021 Feb;46(2):197-212. doi: 10.1007/s11064-020-03155-3. Epub 2020 Oct 26.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验